{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T15:32:09Z","timestamp":1725636729655},"publisher-location":"Heidelberg","reference-count":18,"publisher":"Steinkopff","isbn-type":[{"type":"print","value":"9783642724763"},{"type":"electronic","value":"9783642724749"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1992]]},"DOI":"10.1007\/978-3-642-72474-9_5","type":"book-chapter","created":{"date-parts":[[2011,11,24]],"date-time":"2011-11-24T09:21:53Z","timestamp":1322126513000},"page":"65-71","source":"Crossref","is-referenced-by-count":7,"title":["Phosphodiesterase inhibition and positive inotropy in failing human myocardium"],"prefix":"10.1007","author":[{"given":"W.","family":"Schmitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Eschenhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Mende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. U.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/BF00510259","volume":"311","author":"AC Bauer","year":"1980","unstructured":"Bauer AC, Schwabe U (1980) An improved assay of cyclic 3\u2019,5\u2019-nucleotide phosphodiesterases with QAE-sephadex columns. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 311: 193\u2013198","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"5_CR2","first-page":"1991","volume-title":"Effects of Isomazole on Force of Contraction and Phosphodiesterase Isoenzymes I\u2013IV in Nonfailing and Failing Human Hearts Journal of Cardiovascular Pharmacology 18:386\u2013397","author":"T Bethke","year":"1991","unstructured":"Bethke T, Klimkiewicz A, Kohl C, von der Leyen H, Mehl H, Mende U, Meyer W, Neumann J, Schmitz W, Scholz H, Starbatty J, Stein B, Wenzlaff H, D\u00f6ring V, Kalmar P, and Haverich A (1991) Effects of Isomazole on Force of Contraction and Phosphodiesterase Isoenzymes I\u2013IV in Nonfailing and Failing Human Hearts Journal of Cardiovascular Pharmacology 18:386\u2013397 1991 Raven Press, Ltd., New York"},{"key":"5_CR3","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/oxfordjournals.eurheartj.a062577","volume":"9","author":"M B\u00f6hm","year":"1988","unstructured":"B\u00f6hm M, Beuckelmann D, Brown L, Feiler G, Lorenz B, N\u00e4bauer M, Kemkes B, Erdmann E (1988) Reduction of \u03b2-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium. Eur Heart J 9: 844\u2013852","journal-title":"Eur Heart J"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJM198207223070401","volume":"307","author":"MR Bristow","year":"1982","unstructured":"Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB (1982) Decreased catecholamine sensitivity and \u03b2-adrenergic-receptor density in failing human hearts. N Engl J Med 307: 205\u2013211","journal-title":"N Engl J Med"},{"key":"5_CR5","first-page":"77","volume":"5","author":"MR Bristow","year":"1989","unstructured":"Bristow MR, Port JD, Sandoval AB, Rasmussen R, Ginsburg R, Feldman AM (1989) \u03b2-Adrenergic receptor pathways in the failing human heart. Heart Failure 5: 77\u201390","journal-title":"Heart Failure"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01735205","volume":"66","author":"E Erdmann","year":"1988","unstructured":"Erdmann E (1988) The effectiveness of inotropic agents in isolated cardiac preparations from the human heart. Klin Wochenschr 66: 1\u20136","journal-title":"Klin Wochenschr"},{"key":"5_CR7","first-page":"82","volume-title":"Increase of the 40,000-mol wt pertussis toxin substrate","author":"AM Feldman","year":"1988","unstructured":"Feldman AM, Cates AE, Veazey WB, Hershberger RE, Bristow MR, Baughman KL, Baumgartner WA, Dop C van (1988) Increase of the 40,000-mol wt pertussis toxin substrate ( G protein) in the failing human heart. J Clin Invest 82: 189\u2013197"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1161\/01.CIR.75.2.331","volume":"75","author":"MD Feldman","year":"1987","unstructured":"Feldman MD, Copelas L, Gwathmey JK, Phillips P, Warren SE, Schoen FJ, Grossmann W, Morgan JP (1987) Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation 75: 331\u2013339","journal-title":"Circulation"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/0002-9149(82)90243-0","volume":"49","author":"TB Levine","year":"1982","unstructured":"Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN (1982) Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 49: 1659\u20131666","journal-title":"Am J Cardiol"},{"key":"5_CR10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/BF00167387","volume":"344","author":"H Leyen von der","year":"1991","unstructured":"von der Leyen H, Mende U, Meyer W, Neumann J, Nose M, Schmitz W, Scholz H, Starbatty J, Stein B, Wenzlaff H, D\u00f6ring V, Kalmar P, Haveric A (1991) Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 344: 90\u2013100","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"5_CR11","doi-asserted-by":"crossref","unstructured":"Neumann J, Schmitz W, Scholz H, Meyerinck L von, D\u00f6ring V, Kalm\u00e1r P (1988) Increase in myocardial Grproteins in heart failure. Lancet II: 936\u2013937","DOI":"10.1016\/S0140-6736(88)92601-3"},{"key":"5_CR12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1042\/bj2410535","volume":"241","author":"ML Reeves","year":"1987","unstructured":"Reeves ML, Leigh BK, England PJ (1987) The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Biochem J 241: 535\u2013541","journal-title":"Biochem J"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/0165-6147(87)90234-3","volume":"8","author":"W Schmitz","year":"1987","unstructured":"Schmitz W, Scholz H, Erdmann E (1987) Effects of \u03b1- and \u03b2-adrenergic agonists, phosphodiesterase inhibitors and adenosine on isolated human heart muscle preparations. Trends Pharmacol Sci 8: 447\u2013450","journal-title":"Trends Pharmacol Sci"},{"key":"5_CR14","doi-asserted-by":"crossref","unstructured":"Steinfath M, Danielsen W, von der Leyen H, Mende U, Meyer W, Neumann J, Nose M, Reich T, Schmitz W, Scholz H, Starbatty J, Stein B, D\u00f6ring V, Kalmar P, Haverich A (1992) Reduced \u03b11 and \u03b22-adrenoceptor mediated positive inotropic effects in human end-stage heart failure. Brit J Pharmacol (in press)","DOI":"10.1111\/j.1476-5381.1992.tb14276.x"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0002-9149(78)90162-5","volume":"41","author":"JA Thomas","year":"1978","unstructured":"Thomas JA, Marks BH (1978) Plasma norepinephrine in congestive heart failure. Am J Cardiol 41: 233\u2013243","journal-title":"Am J Cardiol"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1021\/bi00800a014","volume":"10","author":"WJ Thompson","year":"1971","unstructured":"Thompson WJ, Appleman MM (1971) Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochemistry 10: 311\u2013316","journal-title":"Biochemistry"},{"key":"5_CR17","first-page":"69","volume":"10","author":"WJ Thompson","year":"1979","unstructured":"Thompson WJ, Terasaki WL, Epstein PM, Strada SJ (1979) Assay of cyclic nucleotide phosphodiesterase and resolution of multiple molecular forms of the enzyme. Adv Cyclic Nucleotide Res 10: 69\u201392","journal-title":"Adv Cyclic Nucleotide Res"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/cvr\/18.5.302","volume":"18","author":"PT Wilmshurst","year":"1984","unstructured":"Wilmshurst PT, Walker JM, Fry CH, Mounsey JP, Twort CHC, Williams BT, Davies MJ, Webb-Peploe MM (1984) Inotropic and vasodilator effects of amrinone on isolated human tissue. Cardiovasc Res 18: 302\u2013309","journal-title":"Cardiovasc Res"}],"container-title":["Cellular and Molecular Alterations in the Failing Human Heart"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-72474-9_5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T01:59:45Z","timestamp":1606269585000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-72474-9_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992]]},"ISBN":["9783642724763","9783642724749"],"references-count":18,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-72474-9_5","relation":{},"subject":[],"published":{"date-parts":[[1992]]}}}